SAPORITI, GIORGIA NATASCIA
SAPORITI, GIORGIA NATASCIA
Universita' degli Studi di MILANO
Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience
2023 G. Cassanello, F. Serpenti, F. Bagnoli, G. Saporiti, M. Goldaniga, F. Cavallaro, K. Barbullushi, V. Bellani, G. Galassi, F. Onida
Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse
2022 F. Serpenti, M. Sciumè, G. Galassi, G. Saporiti, F. Grifoni, N. Rampi, F. Cavallaro, K. Barbullushi, E. Tagliaferri, M. Goldaniga, L. Baldini, N.S. Fracchiolla, F. Onida
A case of aggressive systemic mastocytosis with bulky lymphadenopathy showing response to midostaurin
2021 M. Sciume, F. Serpenti, S. Muratori, V. Pravettoni, F.M. Ulivieri, G.A. Croci, A.C. Migliorini, A. Esposito, M.C. Goldaniga, G.N. Saporiti, G. Galassi, L. Baldini, F. Onida, F.I. Grifoni
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 B. Fattizzo, J.A. Giannotta, W. Barcellini, M.C. Barbanti, C. Bucelli, R. Cassin, D. Cattaneo, F. Cavallaro, V. Ferla, N.S. Fracchiolla, A. Freyrie, G. Galassi, M.C. Goldaniga, F.I. Grifoni, A. Iurlo, G. Mangiameli, V. Mattiello, M. Meli, A. Neri, A. Noto, F. Onida, L. Ottani, R. Pasquale, L. Pettine, A. Pompa, G. Reda, F.G. Rossi, G.N. Saporiti, M. Sciumè, E. Tagliaferri, L. Baldini
Blastic Plasmacytoid Dendritic Cell Neoplasm: clinic-pathologic and molecular data from a single medical center
2019 S. Alberti-Violetti, D. Fanoni, C. Moltrasio, J. Gliozzo, L. Venegoni, V. Merlo, G. Saporiti, F. Onida, E. Berti
Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients
2018 C. Annaloro, L. Airaghi, D. Giannarelli, G. Mometto, A. Orsatti, G. Saporiti, F.I. Grifoni, M. Baldini, E. Tagliaferri, D. Vincenti, D. Maira, F. Onida, A. Cortelezzi
Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial
2015 A. Rambaldi, A. Grassi, A. Masciulli, C. Boschini, M.C. Micò, A. Busca, B. Bruno, I. Cavattoni, S. Santarone, R. Raimondi, M. Montanari, G. Milone, P. Chiusolo, D. Pastore, S. Guidi, F. Patriarca, A.M. Risitano, G. Saporiti, M. Pini, E. Terruzzi, W. Arcese, G. Marotta, A.M. Carella, A. Nagler, D. Russo, P. Corradini, E.P. Alessandrino, G.F. Torelli, R. Scimè, N. Mordini, E. Oldani, R.M. Marfisi, A. Bacigalupo, A. Bosi
Caratterizzazione molecolare della sindrome di Sezary e possibili risvolti prognostico-terapeutici.
2013 G.N. Saporiti
Cancer stem cells in hematological disorders : current and possible new therapeutic approaches
2011 C. Annaloro, F. Onida, G. Saporiti, G. Lambertenghi Deliliers
New SMAC-Mimetic Compounds Strongly Induce In Vitro Apoptosis of Human Lymphocytes From Patients with Chronic Lymphocytic Leukemia
2010 F. Onida, C. Scavullo, F. Servida, G. Saporiti, P. Seneci, G. Reda, W. Barcellini, A. Cortelezzi, D. Delia, G.L. Deliliers
In vitro anti-leukaemia activity of sphingosine kinase inhibitor
2009 C. Ricci, F. Onida, F. Servida, F. Radaelli, G. Saporiti, K. Todoerti, G. Lambertenghi Deliliers, R. Ghidoni
Long-term clinical and molecular outcomes following RIC-allogeneic HSCT from HLA-identical sibling in patients with advanced mycosis fungoides and Sézary syndrome
2009 F. Onida, E. Berti, G. Saporiti, L. Corti, C. Annaloro, E. Tagliaferri, A. Della Volpe, P. Vezzoli, P. Usardi, G. Lambertenghi Deliliers
Activity of sphingosine kinase inhibitor in Chronic Myelogenous Leukemia cells sensitive and resistant to Imatinib Mesylate
2008 C. Ricci, R. Ghidoni, F. Servida, G. Saporiti, G. Lambertenghi Deliliers, F. Onida
High Frequency of Tumor Suppressor Genes Promoter Hypermethylation in Peripheral Blood of Patients with Myelodysplastic Syndromes
2008 P. Bossolasco, F. Onida, G. Saporiti, C. Bozzi, C. Ricci, A. Cortelezzi, G. Lambertenghi Deliliers
TCRbeta Gene Rearrangements for Detection and Monitoring of Minimal Residual Disease after Allogenic Stem-Cell Transplantation in Patients with Advanced Mycosis Fungoides and Sézary Syndrome
2008 L. Corti, G.N. Saporiti, E. Fermo, E. Berti, L. Venegoni, G. Lambertenghi-Deliliers, F. Onida
Chronic myelomonocytic leukemia : identification of molecular abnormalities and monitoring of ras mutations-driven disease progression by allele-specific PCR
2008 C. Ricci, E. Fermo, A. Cortelezzi, G. Saporiti, A. Vismara, M. Molteni, R. Calori, G. Lambertenghi Deliliers, F. Onida
Evidence of graft-versus-leukaemia following allogeneic haematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome
2008 F. Onida, G. Saporiti, E. Berti, A. Della Volpe, C. Annaloro, E. Tagliaferri, P. Vezzoli, P. Usardi, G. Lambertenghi Deliliers
Single institution retrospective analysis of bronchoalveolar lavage as etiological diagnostic tool for pulmonary infiltrates in patients with haematological malignancies
2008 F. Onida, P. Usardi, C. Annaloro, M.L. Ranzi, G.N. Saporiti, C. Olivares, C. Boschetti, L. Rosso, A. Maraschini, M. Colombi, A. Grancini, A. Della Volpe, N.S. Fracchiolla, G. Lambertenghi Deliliers
Reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation in advanced mycosis fungoides and Sézary syndrome
2007 F. Onida, G. Saporiti, E. Berti, A. Della Volpe, C. Annaloro, P. Usardi, E. Tagliaferri, C. Vener, P. Vezzoli, A. Rambaldi, B. Bruno, G. Lambertenghi Deliliers, E. Berti
Reduced-intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation Represents a Feasible and Effective Treatment Strategy for Advanced Mycosis Fungoides and Sezary Syndrome
2006 D. Soligo, F. Onida, G. Saporiti, A. Della Volpe, C. Marino, C. Annaloro, A. Rambaldi, B. Bruno, E. Berti, F. Lambertenghi Deliliers